0W1Q Stock Overview
MPH Health Care AG, an investment company, engages in the healthcare business in Germany.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
MPH Health Care AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €14.00 |
| 52 Week High | €16.50 |
| 52 Week Low | €14.00 |
| Beta | 1.08 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | -73.04% |
| Change since IPO | -63.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0W1Q | GB Pharmaceuticals | GB Market | |
|---|---|---|---|
| 7D | 0% | 0.2% | -1.4% |
| 1Y | n/a | -5.3% | -2.4% |
Return vs Industry: Insufficient data to determine how 0W1Q performed against the UK Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 0W1Q performed against the UK Market.
Price Volatility
| 0W1Q volatility | |
|---|---|
| 0W1Q Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 8.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0W1Q has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 0W1Q's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 1 | Patrick Brenske | www.mph-ag.de |
MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It produces and sells medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; and develops and sells pharmaceutical and medical products; and provides related services, as well as medical devices for the aesthetic surgery and cosmetic dermatology.
MPH Health Care AG Fundamentals Summary
| 0W1Q fundamental statistics | |
|---|---|
| Market cap | €66.58m |
| Earnings (TTM) | €29.11m |
| Revenue (TTM) | €30.63m |
2.3x
P/E Ratio2.2x
P/S RatioIs 0W1Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0W1Q income statement (TTM) | |
|---|---|
| Revenue | €30.63m |
| Cost of Revenue | €0 |
| Gross Profit | €30.63m |
| Other Expenses | €1.51m |
| Earnings | €29.11m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
Sep 07, 2023
| Earnings per share (EPS) | 6.80 |
| Gross Margin | 100.00% |
| Net Profit Margin | 95.06% |
| Debt/Equity Ratio | 5.9% |
How did 0W1Q perform over the long term?
See historical performance and comparison